Beyond Cholesterol: Landmark deCODE Study Elucidates Role of Lipoprotein(a) as Major Risk Factor for Heart Disease
Highly diverse, understudied and not routinely screened for, Lp(a) — an alipoprotein(a) bound to an LDL cholesterol particle — may be the next most important serum risk factor after LDL itself Results provide population-based evidence in support of standardized...
deCODE in Iceland agrees to sequence half of UK Biobank participants
REYKJAVIK, Iceland, 11. September. 2019. deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake whole genome sequencing of UK Biobank...
Kári Stefánsson elected to National Academy of Science
Kári Stefánsson, the founder and CEO of deCODE Genetics, now a subsidiary of Amgen, has been elected to the National Academy of Science (NAS). Election to the academy is one of the highest honors in the field of science and a recognition reserved for individuals whose careers are distinguished by original and continuing achievements in their areas of research.
Leaders of Nordic Society of Human Genetics and Precision Medicine
Kári Stefánsson CEO of deCODE genetics seeks to unite Nordic researchers in genetic research to support more precise and personalised medical treatment . The Nordic Society of Human Genetics and Precision Medicine (NSHG-PM) has chosen its inaugural leadership....
UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.